-
Most Recent
Search Results
240 results for abv
Is Valeant Pharmaceuticals Intl Inc (VRX) Stock Worth the Risk?
Valeant Pharmaceuticals has had a rocky road, but if things improve from here on out, VRX stock could rise five-fold from current levels.
Opendoor’s Rebirth: Can the Army Turn Meme Momentum Into Millions?
Opendoor is back from the brink with new leadership, fresh capital, and a bold AI-driven strategy. Is it the biggest turnaround of 2025?
The Market’s Smoke Alarm: What the Yield Curve Is Telling Traders in 2025
After the longest inversion in history, the yield curve has snapped back into positive territory. Some pundits are calling it a sign of confidence. Others…
5 All-In Summit Tech Trends Driving the Next Boom
Tech leaders at the All-In Summit—from Elon Musk to Palantir’s Alex Karp—unveiled groundbreaking shifts in AI, finance, energy, and space. Investor Luke Lango shares five…
What Satellites Can Teach Us About 1,000% Stocks
In finance, apogee describes when a stock is furthest away from its ultimate potential. And that’s an important point of my new stock-picking system, Apogee.…
Cobotic Investing: Man Plus Machine Makes the Smartest Trades
AI is reshaping investing. Eric Fry’s Apogee system fuses machine power with human strategy to spot tomorrow’s biggest 10X stock winners.
How One Pattern Predicted Nvidia’s 1,871% Run
Inside Eric Fry’s powerful new stock-picking system designed to pinpoint precisely when a stock enters the “10X pattern.”
Why Japan May Be the Market That Supercharges Your Portfolio
In today’s Smart Money, let’s break down Japan’s economic journey to explain why it’s responsible for the best performing companies of the past month. This…
The Hidden Sweet Spot Where 1,000% Winners Live
For the first time, I have translated my internal locating system into a computerized, quantitative set of rules… a powerful new stock-picking system designed to…
ABM’s Dividend Increase Won’t Keep it Above $30
This morning I am recommending a bearish trade on ABM Industries, Inc. (NYSE:ABM), a provider of facility services like parking, janitorial services and building and…
Trade of the Day: AbbVie (ABBV)
In 2017, Humira raked in $18.9 billion in sales for AbbVie (ABBV) and, according to the company’s latest earnings announcement, that sales rate grew by…
Strong Buy for AbbVie (ABBV) This Week
AbbVie (ABBV) remains a Strong Buy this week based on the most current relative pricing of its shares and analysis.
Strong Buy for AbbVie (ABBV) This Week
The Strong Buy for AbbVie (ABBV) this week is based on the latest stock market rankings, and relative pricing of its shares.
Strong Buy for AbbVie (ABBV) This Week
At $114.93, AbbVie (ABBV) a Strong Buy based on the most recent SEC filings, and comparative pricing of its shares.
Strong Buy for AbbVie (ABBV) This Week
At $118.94, AbbVie (ABBV) a Strong Buy based on the most recent SEC filings, and comparative pricing of its shares.
AbbVie (ABBV) a Buy on Healthy Earnings Momentum
AbbVie Inc (NYSE:ABBV) is ranked as a Buy using the approach to investing of Louis Navellier and his Portfolio Grader stock evaluator. This represents no…
AbbVie (ABBV) a Buy on Strong Quant Score
Currently, AbbVie Inc (NYSE:ABBV) has a Buy using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. ABBV has maintained this…
6 – 10 of 240 results
